Main Session
Sep 29
PQA 06 - Radiation and Cancer Biology, Health Care Access and Engagement

3085 - Impact of KRAS Mutation Status on Long-Term Oncological Outcomes in Unresectable Stage III NSCLC Treated with Chemoradiation with or without Immunotherapy

05:00pm - 06:00pm PT
Hall F

Presenter(s)

Ritesh Kumar, MD Headshot
Ritesh Kumar, MD - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ